Feb 05, 2020 / 05:00PM GMT
William G. Rice - Aptose Biosciences Inc. - Chairman, President & CEO
Good afternoon, everyone. According to the name badge, I'm Dr. William Rice. I'm the Chairman and CEO of Aptose Biosciences. And I want to welcome you here this afternoon and also thank you for joining us for this KOL event both all of you who are present today as well as those who are listening remotely.
I also want to, before we get into the activities, introduce everybody to the members of the management team that are here today. You see, Mr. Greg Chow, over by the door, Chief Financial Officer; Dr. Joti Marango, Chief Business Officer, also over by the door; and here, we have Dr. Rafael Bejar, our Chief Medical Officer. So hopefully, I have the opportunity to engage all these individuals, okay?
So finally, let's talk about or remind you of why we're here today. So I would -- I suspect, on many occasions, you've heard me talk about our small-molecule kinase inhibitor, known as CG-806. We've also -- we refer to it as 806. This molecule is a highly -- has a highly unique kinase inhibitory profile, and that unique
Aptose Biosciences Inc. - Special Call Transcript
Feb 05, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers